Meldonium solution for injection 100 mg/ml ampoule 5 ml No. 10




Meldonium injection solution is indicated in the complex therapy of diseases:
diseases of the heart and vascular system: stable angina pectoris, chronic heart failure (NYHA I-III and functional class), cardiomyopathy, functional disorders of the heart and vascular system; acute and chronic ischemic disorders of cerebral circulation; reduced working capacity, physical and psycho-emotional overstrain; during the recovery period after cerebrovascular disorders, head injuries and encephalitis.Composition
Active ingredient: meldonium;
1 ml meldonium (3-(2,2,2-trimethylhydrazinium) propionate dihydrate) 100 mg;
5 ml of solution (1 ampoule) contain meldonium (3-(2,2,2-trimethylhydrazinium) propionate dihydrate) 500 mg;
Excipients: sodium hydroxide, diluted hydrochloric acid, water for injections.
Contraindication
hypersensitivity to meldonium and/or any of the excipients of the drug; increased intracranial pressure (in case of impaired venous outflow, intracranial tumors); severe hepatic and/or renal failure (there is insufficient data on the safety of use).Method of application
Intravenously. The use of the drug does not require special preparation before administration.
Due to the possible stimulating effect, the drug is recommended to be used in the morning.
Adults. The dose is 500-1000 mg (5-10 ml) into a vein, administered as a single dose or in two divided doses. The duration of treatment is usually 10-14 days, after which the treatment is continued with an oral dosage form. The duration of the course of treatment is 4-6 weeks. The course of treatment can be repeated 2-3 times a year.
Elderly patients. Elderly patients with impaired liver and/or kidney function may require a reduced dose of meldonium.
Patients with renal impairment. Since the drug is excreted from the body by the kidneys, patients with mild to moderate renal impairment should use a lower dose of meldonium.
Patients with hepatic impairment. Patients with mild to moderate hepatic impairment should be given a lower dose of meldonium.
Application features
Pregnant women
Contraindicated.
Children
Contraindicated.
Overdose
There have been no reports of overdoses of meldonium. The drug is low-toxic and does not cause any dangerous side effects.
Low blood pressure may cause headache, dizziness, tachycardia, and weakness. Treatment is symptomatic.
In case of severe overdose, liver and kidney function should be monitored.
Hemodialysis is not of significant importance in case of meldonium overdose due to pronounced binding to blood proteins.
Side effects
headache; allergic reactions; dispersion; dyslipidemia; increased C-reactive protein levels.Interaction
Meldonium can be used together with long-acting nitrates and other antianginal drugs (stable angina of exertion), cardiac glycosides and diuretics (heart failure). It can also be combined with anticoagulants, antiplatelet agents, antiarrhythmics and other drugs that improve microcirculation.
Meldonium may enhance the effects of drugs containing glyceryl trinitrate, nifedipine, beta-blockers and other antihypertensive agents and peripheral vasodilators.
Storage conditions
Store at a temperature not exceeding 25 °C in the original packaging. Do not freeze.
Keep out of reach of children.
Shelf life - 2 years.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.